Globus Medical Pre-Tax Profit Margin 2012-2026 | GMED
Current and historical pre-tax profit margin for Globus Medical (GMED) from 2012 to 2026. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Globus Medical pre-tax profit margin for the three months ending March 31, 2026 was .
| Globus Medical Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2026-03-31 | $3.10B | $0.66B | 21.23% |
| 2025-12-31 | $2.94B | $0.61B | 20.59% |
| 2025-09-30 | $2.77B | $0.46B | 16.65% |
| 2025-06-30 | $2.63B | $0.37B | 14.24% |
| 2025-03-31 | $2.51B | $0.23B | 9.32% |
| 2024-12-31 | $2.52B | $0.12B | 4.80% |
| 2024-09-30 | $2.48B | $0.12B | 4.88% |
| 2024-06-30 | $2.24B | $0.07B | 2.99% |
| 2024-03-31 | $1.90B | $0.09B | 4.95% |
| 2023-12-31 | $1.57B | $0.17B | 10.57% |
| 2023-09-30 | $1.23B | $0.20B | 16.54% |
| 2023-06-30 | $1.10B | $0.26B | 23.79% |
| 2023-03-31 | $1.07B | $0.26B | 24.04% |
| 2022-12-31 | $1.02B | $0.24B | 23.75% |
| 2022-09-30 | $1.00B | $0.20B | 20.12% |
| 2022-06-30 | $0.98B | $0.19B | 19.90% |
| 2022-03-31 | $0.96B | $0.17B | 17.88% |
| 2021-12-31 | $0.96B | $0.18B | 18.79% |
| 2021-09-30 | $0.94B | $0.22B | 23.59% |
| 2021-06-30 | $0.93B | $0.22B | 23.84% |
| 2021-03-31 | $0.83B | $0.15B | 18.18% |
| 2020-12-31 | $0.79B | $0.13B | 15.84% |
| 2020-09-30 | $0.77B | $0.12B | 15.23% |
| 2020-06-30 | $0.75B | $0.11B | 14.84% |
| 2020-03-31 | $0.79B | $0.18B | 22.67% |
| 2019-12-31 | $0.79B | $0.19B | 24.17% |
| 2019-09-30 | $0.77B | $0.18B | 23.90% |
| 2019-06-30 | $0.74B | $0.18B | 24.23% |
| 2019-03-31 | $0.72B | $0.18B | 25.38% |
| 2018-12-31 | $0.71B | $0.19B | 26.54% |
| 2018-09-30 | $0.69B | $0.19B | 27.75% |
| 2018-06-30 | $0.68B | $0.19B | 27.56% |
| 2018-03-31 | $0.65B | $0.18B | 26.91% |
| 2017-12-31 | $0.64B | $0.17B | 26.73% |
| 2017-09-30 | $0.61B | $0.16B | 25.33% |
| 2017-06-30 | $0.60B | $0.16B | 26.34% |
| 2017-03-31 | $0.58B | $0.16B | 26.68% |
| 2016-12-31 | $0.56B | $0.16B | 27.84% |
| 2016-09-30 | $0.56B | $0.18B | 31.89% |
| 2016-06-30 | $0.56B | $0.18B | 32.19% |
| 2016-03-31 | $0.55B | $0.18B | 32.19% |
| 2015-12-31 | $0.55B | $0.17B | 31.50% |
| 2015-09-30 | $0.53B | $0.16B | 29.14% |
| 2015-06-30 | $0.51B | $0.15B | 29.04% |
| 2015-03-31 | $0.49B | $0.14B | 29.21% |
| 2014-12-31 | $0.48B | $0.14B | 29.05% |
| 2014-09-30 | $0.46B | $0.13B | 28.42% |
| 2014-06-30 | $0.45B | $0.13B | 28.00% |
| 2014-03-31 | $0.44B | $0.11B | 23.70% |
| 2013-12-31 | $0.43B | $0.10B | 23.73% |
| 2013-09-30 | $0.42B | $0.10B | 23.81% |
| 2013-06-30 | $0.41B | $0.10B | 23.77% |
| 2013-03-31 | $0.40B | $0.12B | 29.22% |
| 2012-12-31 | $0.39B | $0.11B | 29.46% |
| 2012-09-30 | $0.37B | $0.11B | 29.14% |
| 2012-06-30 | $0.36B | $0.11B | 29.75% |
| 2012-03-31 | $0.35B | $0.10B | 29.31% |
| 2011-12-31 | $0.33B | $0.10B | 29.31% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $10.750B | $2.939B |
| Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its sales operations distributed across counties world wide. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and unique surgical instruments, used in an expansive range of spinal, orthopedic and neurosurgical procedures. The spine products address the vast majority of conditions affecting the spine including degenerative conditions, deformity, tumors and trauma. Enabling Technologies are designed to enhance a surgeon's capabilities and streamline the complicated surgical procedures to be safer, less invasive, accurate and more reproducible to improve patient care and reduce radiation exposure for both patient and caregiver. The technology contains imaging, navigation and robotic assisted surgery solutions. It acquired all assets of StelKast, Inc. and Finnish engineering company Synoste Oy. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $172.436B | 20.03 |
| Intuitive Surgical (ISRG) | United States | $142.710B | 51.59 |
| Edwards Lifesciences (EW) | United States | $49.450B | 31.81 |
| IDEXX Laboratories (IDXX) | United States | $43.049B | 40.19 |
| Waters (WAT) | United States | $35.175B | 26.38 |
| Alcon (ALC) | Switzerland | $32.239B | 20.50 |
| IQVIA Holdings (IQV) | United States | $28.007B | 15.06 |
| DexCom (DXCM) | United States | $26.652B | 29.64 |
| Mettler-Toledo (MTD) | United States | $23.523B | 26.75 |
| STERIS (STE) | Ireland | $19.531B | 19.70 |
| Hologic (HOLX) | United States | $16.752B | 17.53 |
| SONOVA HOLDING (SONVY) | Switzerland | $14.276B | 0.00 |
| Coloplast (CLPBY) | Denmark | $12.868B | 17.30 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.635B | 9.28 |
| Penumbra (PEN) | United States | $12.437B | 82.56 |
| Masimo (MASI) | United States | $9.578B | 30.69 |
| Glaukos (GKOS) | United States | $7.705B | 0.00 |
| SARTORIUS (SSSGY) | Germany | $7.521B | 43.67 |
| Teleflex (TFX) | United States | $5.386B | 11.35 |
| Sysmex ADR (SSMXY) | Japan | $5.369B | 22.45 |
| LivaNova (LIVN) | United Kingdom | $4.324B | 22.49 |
| Veracyte (VCYT) | United States | $4.244B | 36.43 |
| Integer Holdings (ITGR) | United States | $3.059B | 14.30 |
| TransMedics (TMDX) | United States | $2.610B | 30.82 |
| AxoGen (AXGN) | United States | $2.390B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $1.821B | 19.76 |
| UFP Technologies (UFPT) | United States | $1.805B | 23.78 |
| Pulse Biosciences (PLSE) | United States | $1.779B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $1.460B | 12.38 |
| Integra LifeSciences Holdings (IART) | United States | $1.369B | 7.46 |
| Alphatec Holdings (ATEC) | United States | $1.315B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $1.199B | 0.00 |
| IRadimed (IRMD) | United States | $1.172B | 50.10 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.167B | 27.67 |
| OPKO Health (OPK) | United States | $1.080B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $0.983B | 0.00 |
| Artivion (AORT) | United States | $0.977B | 30.97 |
| Anteris Technologies Global (AVR) | Australia | $0.934B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.906B | 0.00 |
| SiBone (SIBN) | United States | $0.702B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.610B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.591B | 29.80 |
| NeuroPace (NPCE) | United States | $0.524B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.515B | 13.65 |
| AngioDynamics (ANGO) | United States | $0.512B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.512B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.466B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.410B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.397B | 1151.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.362B | 0.00 |
| 908 Devices (MASS) | United States | $0.327B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Sight Sciences (SGHT) | United States | $0.285B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.283B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.260B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.209B | 0.00 |
| RxSight (RXST) | United States | $0.205B | 0.00 |
| FocalTherics (FOCL) | France | $0.184B | 0.00 |
| Inogen (INGN) | United States | $0.174B | 0.00 |
| Hyperfine (HYPR) | United States | $0.148B | 0.00 |
| CVRx (CVRX) | United States | $0.129B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.124B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.124B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.113B | 0.00 |
| Neuronetics (STIM) | United States | $0.084B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.078B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.078B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.073B | 0.00 |
| LENSAR (LNSR) | United States | $0.069B | 0.00 |
| Positron (POSC) | United States | $0.059B | 0.00 |
| Precision Optics (POCI) | United States | $0.059B | 0.00 |
| Spectral AI (MDAI) | United States | $0.055B | 0.00 |
| Envoy Medical (COCH) | United States | $0.051B | 0.00 |
| DarioHealth (DRIO) | United States | $0.046B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.046B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.045B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.043B | 0.00 | |
| Accuray (ARAY) | United States | $0.037B | 0.00 |
| InspireMD (NSPR) | United States | $0.034B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.032B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.015B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.010B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.007B | 0.00 |
| NexGel (NXGL) | United States | $0.006B | 0.00 |
| PAVmed (PAVM) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| ENvue Medical (FEED) | United States | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |